Elevated expression of CTGF was positively associated with progression and poor prognosis in melanoma, papillary thyroid carcinoma, esophageal squamous cell carcinoma, gastric cancer, and cervical tumors [18]–[22]. This evidence concerns the gene CCN2 and thyroid gland papillary carcinoma.